Phospho-MYL12A/MYL12B/MYL9 (T17/S18) Antibody

What are MYL12A, MYL12B, and MYL9 proteins, and why study their phosphorylation?

MYL12A, MYL12B, and MYL9 are myosin regulatory light chain proteins that play crucial roles in regulating both smooth muscle and nonmuscle cell contractile activity through their phosphorylation states. MYL12A and MYL12B function as non-muscle myosin regulatory light chains (MRLCs), while MYL9 is categorized as a smooth muscle MRLC. These proteins serve as essential components in cellular processes including cytokinesis, receptor capping, and cell locomotion . Phosphorylation of these proteins, particularly at threonine 17/18 and serine 18/19 residues, triggers actin polymerization in vascular smooth muscle and regulates actomyosin interactions that control cellular shape changes and motility . Additionally, MYL12A and MYL12B are critical for maintaining the stability of other myosin components (MYH9, MYH10, and MYL6), which ensures normal cell actomyosin function .

What are the key applications for Phospho-MYL12A/MYL12B/MYL9 (T17/S18) antibodies?

Phospho-MYL12A/MYL12B/MYL9 (T17/S18) antibodies are validated for multiple research applications including:

• Western blotting: For quantitative analysis of phosphorylation levels in different experimental conditions

• Immunohistochemistry (IHC): Typically at dilutions of 1:100-1:300 for visualizing phosphorylation patterns in tissue sections

• Immunofluorescence: For examining subcellular localization of phosphorylated proteins

• Enzyme-linked immunosorbent assay (ELISA): For quantitative measurement in solution

• Immunoprecipitation: For isolation of phosphorylated protein complexes

These applications allow researchers to investigate phosphorylation-dependent signaling pathways involved in cellular functions including cell motility, contraction, and cytoskeletal organization across human, mouse, and rat experimental models .

How do different tissue and cell types express MYL12A/B and MYL9?

Expression patterns of these proteins vary across tissues and cellular structures. Research using droplet digital PCR has revealed that hair cells (HCs) express both MYL12A/B and MYL9 . Immunofluorescence studies of the organ of Corti demonstrated that MYL12 is exclusively expressed in the apical portion of HCs, while both MYL12 and MYL9 are expressed on inner supporting cells (ISCs) . This differential expression pattern suggests specialized functions in different cellular compartments and tissue types. When conducting research using these antibodies, it's important to consider the specific expression profile of your target tissue to correctly interpret phosphorylation patterns observed in experimental results .

What factors should be optimized when using Phospho-MYL12A/MYL12B/MYL9 (T17/S18) antibodies for immunohistochemistry?

When employing these antibodies for immunohistochemistry, researchers should consider several critical optimization parameters:

• Fixation methods: Different fixatives can affect epitope accessibility. Paraformaldehyde fixation is commonly used, but duration and concentration should be optimized for your specific tissue.

• Antigen retrieval: Heat-induced epitope retrieval in citrate buffer (pH 6.0) often enhances detection of phospho-epitopes.

• Blocking parameters: Use 0.5% BSA (similar to the storage buffer composition) to minimize background .

• Antibody dilution: Starting with the recommended range of 1:100-1:300, perform a dilution series to identify optimal signal-to-noise ratio for your specific tissue type .

• Incubation conditions: Temperature and duration significantly impact antibody binding kinetics, with overnight incubation at 4°C often yielding superior results for phospho-specific antibodies.

• Visualization methods: For co-localization studies, researchers studying auditory epithelia have successfully combined these antibodies with rhodamine phalloidin to visualize F-actin structures, incubating in PBS for 45 minutes at room temperature before imaging with confocal microscopy .

How can researchers distinguish between phosphorylation of MYL12A, MYL12B, and MYL9 in experimental samples?

Distinguishing between phosphorylation of the different isoforms presents a significant technical challenge due to high sequence homology. A strategic experimental approach includes:

• Complementary techniques: Combine the phospho-specific antibody detection with isoform-specific detection through RT-PCR or Western blotting with non-phospho antibodies.

• Selective knockdown: Use siRNA or CRISPR techniques to selectively diminish individual isoforms before phosphorylation analysis.

• Mass spectrometry validation: For definitive identification, phosphopeptide mapping via mass spectrometry can distinguish between isoforms based on unique peptide sequences flanking the phosphorylation sites.

• Purified protein standards: Include purified phosphorylated versions of each protein (as described in the literature where MYL12B was purified and phosphorylated by smMLCK in vitro) as positive controls to establish isoform-specific migration patterns or reactivity profiles .

• Blocking peptide studies: Utilize isoform-specific blocking peptides to confirm antibody specificity, which are available upon special request from antibody manufacturers .

What is the optimal protocol for expressing and purifying MYL12B for in vitro phosphorylation studies?

For researchers investigating phosphorylation mechanisms in vitro, expressing and purifying MYL12B provides essential experimental material. A validated protocol includes:

• Gene cloning: PCR amplify MYL12B (gene accession no. NM_033546) using forward primer 5′-caccatgtcgagcaaaaaggcaaagaccaa-3′ and reverse primer 5′-tcagtcatctttgtctttggctccatgttt-3′ .

• Vector construction: Subclone amplified cDNA into pENTR/D-TOPO vector and insert into pDEST17 vector using Gateway Technology System according to manufacturer's protocol .

• Bacterial expression: Transform pDEST17 constructs into BL21 chemically competent E. coli. Culture in lysogeny broth with 100 μg/mL ampicillin until OD600 reaches 0.5, then induce expression with 0.2% arabinose for 2 hours at 37°C .

• Cell harvesting: Harvest cells by centrifugation at 5000× g at 4°C for 10 minutes. Resuspend pellet in PBS containing EDTA-free protease inhibitor cocktail .

• Protein isolation: Isolate inclusion bodies containing N-terminus His-tagged MYL12B protein using a French press .

• Protein purification: Solubilize the inclusion body pellet in IMAC binding buffer (10 mM HEPES [pH 7.4], 0.5 M NaCl, 1 mM MgCl2, 0.1% CHAPS, 6 M urea) and rotate at 4°C for 1 hour. After centrifugation, load the protein solution onto a TALON Metal Affinity Resin column equilibrated with IMAC binding buffer at 4°C .

• Elution and refolding: Elute bound protein with elution buffer (50 mM Sodium phosphate [pH 8.0], 0.3 M NaCl, 0.1% CHAPS, 0.15 M Imidazole), then refold and concentrate by centrifugation at 5000× g .

This protocol yields functional MYL12B that can be used for in vitro phosphorylation assays with kinases such as smooth muscle myosin light chain kinase (smMLCK).

How does the phosphorylation of MYL12 by myosin light chain kinase contribute to cellular morphology?

The phosphorylation of MYL12 by smooth muscle myosin light chain kinase (smMLCK) induces significant morphological changes in cells through several mechanisms:

• Apical constriction: Research demonstrates that MYL12 phosphorylation by smMLCK contributes to apical constriction-like cellular shape changes in hair cells (HCs), potentially relating to the development of auditory epithelia and hearing function .

• Contractile force generation: Phosphorylation activates myosin ATPase activity, enabling actomyosin contraction that drives cell shape changes. When phosphorylation is reduced using ML-7 (an inhibitor of smMLCK), researchers observed expansion of the cell area of outer HCs, confirming the critical role of phosphorylation in maintaining cellular morphology .

• Cytoskeletal reorganization: Phosphorylated MYL12 regulates interaction with actin filaments, orchestrating the cytoskeletal rearrangements necessary for coordinated cellular processes including division, migration, and differentiation .

• Mechanotransduction pathways: In myoblasts, similar phosphorylation events in MYL9 regulate PIEZO1-dependent cortical actomyosin assembly involved in myotube formation, suggesting conserved mechanisms across myosin regulatory light chains .

These findings highlight the importance of studying phosphorylation states to understand fundamental cellular processes and their potential implications in development and disease.

What experimental approaches can determine the functional consequences of altered MYL12/MYL9 phosphorylation?

To investigate the functional impact of altered phosphorylation states, researchers employ multiple complementary approaches:

• Pharmacological inhibition: Utilizing specific inhibitors like ML-7 to block smMLCK activity and observe resultant changes in cellular morphology and function, as demonstrated in studies where ML-7 treatment led to expansion of outer hair cell areas .

• Site-directed mutagenesis: Generating phosphomimetic (T→D or S→D) or phosphodeficient (T→A or S→A) mutants to simulate constitutively phosphorylated or unphosphorylated states, respectively.

• Live-cell imaging: Combining phospho-specific antibody staining with fluorescent actin markers (such as rhodamine phalloidin) to visualize dynamic cytoskeletal changes in response to phosphorylation events .

• Quantitative morphometric analysis: Measuring parameters such as cell area, aspect ratio, and mechanical properties to correlate phosphorylation levels with specific cellular phenotypes.

• Force measurements: Using traction force microscopy or atomic force microscopy to quantify changes in cellular contractility associated with different phosphorylation states.

• Calcium signaling integration: As activation of smooth and cardiac muscle involves pathways that increase calcium levels and myosin phosphorylation , calcium imaging can be paired with phosphorylation studies to map the complete signaling cascade.

What are common challenges when working with phospho-specific antibodies, and how can researchers address them?

Phospho-specific antibodies present several technical challenges that researchers should anticipate and address:

• Epitope masking: Phosphorylation sites may be masked by protein-protein interactions or conformation changes. Solution: Use denaturing conditions for Western blots and optimize antigen retrieval for IHC/IF applications.

• Phosphatase activity: Endogenous phosphatases can rapidly dephosphorylate targets during sample preparation. Solution: Include phosphatase inhibitors (e.g., sodium fluoride, sodium orthovanadate, β-glycerophosphate) in all buffers used during sample preparation.

• Cross-reactivity: Phospho-antibodies may recognize similar phosphorylation motifs on different proteins. Solution: Validate specificity using phosphatase treatment controls and blocking peptide competition assays, which are available upon request from manufacturers .

• Temporal dynamics: Phosphorylation events are often transient. Solution: Perform time-course experiments to capture the optimal window for detection, particularly when studying stimulus-induced phosphorylation.

• Quantification challenges: Normalizing phospho-signals to total protein can be complicated. Solution: Strip and reprobe membranes with antibodies against the total (phosphorylated and non-phosphorylated) protein, or use dual-color detection systems.

• Species cross-reactivity: While antibodies are typically validated for human, mouse, and rat samples , use in other species requires validation. Some researchers have inquired about primate tissue compatibility, which may require testing through manufacturer innovation programs .

How can researchers optimize detection methods for low-abundance phosphorylated MYL12A/MYL12B/MYL9?

Detecting low-abundance phosphorylated proteins requires specialized approaches:

• Sample enrichment strategies:

  • Immunoprecipitation before Western blotting

  • Phosphoprotein enrichment using metal oxide affinity chromatography (MOAC)

  • Subcellular fractionation to concentrate relevant compartments

• Signal amplification techniques:

  • Tyramide signal amplification for immunohistochemistry

  • Enhanced chemiluminescence substrates with extended reaction times

  • Highly sensitive fluorescent secondary antibodies

• Optimized buffer systems:

  • Use of RIPA buffer with phosphatase inhibitors for protein extraction

  • Inclusion of 0.5% BSA in blocking buffers (matching storage buffer composition)

  • Optimization of primary antibody incubation times (extended overnight incubation at 4°C)

• Detection system selection:

  • For Western blotting, choosing appropriate membrane type (PVDF often provides better retention of phosphoproteins than nitrocellulose)

  • Using high-sensitivity imaging systems with extended exposure times

  • Employing digital accumulation methods for weak fluorescent signals

How does MYL12/MYL9 phosphorylation contribute to auditory system development and function?

Research has revealed significant roles for MYL12/MYL9 phosphorylation in auditory system biology:

• Cell-specific expression patterns: Studies using droplet digital PCR and immunofluorescence staining have shown that hair cells (HCs) express both MYL12A/B and MYL9, with MYL12 specifically localized to the apical portion of HCs, while both MYL12 and MYL9 are expressed on inner supporting cells (ISCs) .

• Morphological regulation: MYL12 phosphorylation by smMLCK contributes to apical constriction-like cellular shape changes in HCs, which appears to play a critical role in the development of auditory epithelia and ultimately hearing function .

• Response to inhibition: When MYL12 phosphorylation is reduced using the smMLCK inhibitor ML-7, researchers observed expansion of the cell area of outer HCs, confirming the importance of this phosphorylation in maintaining cellular architecture in the auditory system .

• Visualization techniques: These phosphorylation events can be studied through confocal imaging using FV1000 laser scanning microscopy with WHN10x/22 ocular lens and UCPLFLN 100× objective lens, with Z-projections processed using specialized software .

This research highlights how the study of myosin light chain phosphorylation contributes to our understanding of specific developmental and functional processes in specialized tissues like the auditory system.

What role does phosphorylation of these proteins play in smooth muscle contraction and vascular function?

Phosphorylation of MYL12A/B and MYL9 represents a critical regulatory mechanism in smooth muscle physiology:

• Contractile activation: Activation of smooth muscle primarily involves pathways that increase calcium levels, leading to myosin phosphorylation and subsequent contraction . This phosphorylation occurs primarily at threonine 17/18 and serine 18/19 residues.

• Actin polymerization: Phosphorylation of these myosin regulatory light chains specifically triggers actin polymerization in vascular smooth muscle, a fundamental process in vascular tone regulation .

• Signaling integration: The phosphorylation state serves as an integration point for multiple signaling pathways, including calcium-dependent activation of myosin light chain kinase and RhoA/ROCK-mediated inhibition of myosin phosphatase.

• Vascular pathophysiology: Dysregulation of this phosphorylation mechanism contributes to vascular pathologies including hypertension, vasospasm, and atherosclerosis, making these antibodies valuable tools for cardiovascular research.

• Therapeutic implications: Understanding these phosphorylation events helps identify potential therapeutic targets for vascular disorders, as modulation of myosin light chain phosphorylation could normalize vascular reactivity in pathological states.